AVBP - CIK 0001868279
ArriVent BioPharma, Inc. (AVBP) reported net income of -$166.31M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$166.31M | -106.6% |
| FY 2024 | -$80.49M | -16.1% |
| FY 2023 | -$69.33M | - |
ArriVent BioPharma, Inc. (AVBP) reported net income of -$166.31M for fiscal year 2025, as filed in its audited annual report with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.